Eflornithine

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Eflornithine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Eflornithine (IV): no longer commercially available in the U.S.
  • Treatment of unwanted facial hair in women (topical cream)

NON-FDA APPROVED USES

  • African trypanosomiasis (sleeping sickness):Second-stage T. b. gambiense
    • Eflornithine is not effective against T. b. rhodesiense(East African form of the diseases)
    • Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email, parasites@cdc.gov).

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 3, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Eflornithine ID - 540184 A1 - Avdic,Edina,Pharm.D. AU - Pham,Paul,Pharm.D. Y1 - 2017/06/03/ PB - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540184/all/Eflornithine ER -